0	1	They	they	PRP	nsubj	3	O	 (ROOT (S (S (NP (PRP They))	0	4
0	2	can	can	MD	aux	3	O	 (VP (MD can)	5	8
0	3	prevent	prevent	VB	root	0	O	 (VP (VB prevent)	9	16
0	4	infection	infection	NN	obj	3	CAUSE_OF_DEATH	 (NP (NN infection))	17	26
0	5	to	to	IN	case	9	O	 (PP (IN to)	27	29
0	6	a	a	DT	det	9	O	 (NP (NP (DT a)	30	31
0	7	very	very	RB	advmod	8	O	 (ADJP (RB very)	32	36
0	8	significant	significant	JJ	amod	9	O	 (JJ significant))	37	48
0	9	extent	extent	NN	obl	3	O	 (NN extent))	49	55
0	10	,	,	,	punct	9	O	 (, ,)	55	56
0	11	the	the	DT	det	13	O	 (NP (DT the)	57	60
0	12	exact	exact	JJ	amod	13	O	 (JJ exact)	61	66
0	13	percentage	percentage	NN	appos	9	O	 (NN percentage))))	67	77
0	14	depend	depend	VB	dep	3	O	 (S (VP (VB depend)	78	84
0	15	on	on	IN	case	21	O	 (PP (IN on)	85	87
0	16	dose	dose	NN	compound	21	O	 (NP (NP (NN dose)	88	92
0	17	number	number	NN	compound	21	O	 (NN number)	93	99
0	18	,	,	,	punct	21	O	 (, ,)	99	100
0	19	variant	variant	NN	dep	21	O	 (NN variant)	101	108
0	20	,	,	,	punct	21	O	 (, ,)	108	109
0	21	time	time	NN	obl	14	O	 (NN time))	110	114
0	22	etc	etc	FW	conj	21	O	 (ADVP (FW etc)))))))))	115	118
0	23	-	-	:	punct	3	O	 (: -)	119	120
0	24	this	this	DT	det	25	O	 (S (NP (NP (DT this)	121	125
0	25	study	study	NN	nsubj	28	O	 (NN study))	126	131
0	26	for	for	IN	case	27	O	 (PP (IN for)	132	135
0	27	example	example	NN	nmod	25	O	 (NP (NN example))))	136	143
0	28	reported	report	VBD	parataxis	3	O	 (VP (VBD reported)	144	152
0	29	boosters	booster	NNS	nsubj	30	O	 (S (NP (NNS boosters))	153	161
0	30	prevent	prevent	VB	ccomp	28	O	 (VP (VB prevent)	162	169
0	31	93	93	CD	nummod	32	PERCENT	 (NP (NP (CD 93)	170	172
0	32	%	%	NN	obj	30	PERCENT	 (NN %))	172	173
0	33	of	of	IN	case	35	O	 (PP (IN of)	174	176
0	34	the	the	DT	det	35	O	 (NP (DT the)	177	180
0	35	infections	infection	NNS	nmod	32	CAUSE_OF_DEATH	 (NNS infections)))	181	191
0	36	,	,	,	punct	32	O	 (, ,)	191	192
0	37	including	include	VBG	case	38	O	 (PP (VBG including)	193	202
0	38	asymptomatic	asymptomatic	JJ	nmod	32	O	 (NP (JJ asymptomatic))))))))	203	215
0	39	.	.	.	punct	3	O	 (. .)))	215	216

1	1	"	"	``	punct	11	O	 (ROOT (S (`` ")	217	218
1	2	The	the	DT	det	3	O	 (NP (NP (DT The)	218	221
1	3	incidence	incidence	NN	nsubj	11	O	 (NN incidence))	222	231
1	4	of	of	IN	case	9	O	 (PP (IN of)	232	234
1	5	SARS	SARS	NNP	compound	9	O	 (NP (NNP SARS)	235	239
1	6	-	-	HYPH	punct	9	O	 (HYPH -)	239	240
1	7	CoV	CoV	NNP	compound	9	O	 (NNP CoV)	240	243
1	8	-	-	HYPH	punct	9	O	 (HYPH -)	243	244
1	9	2	2	NNP	nmod	3	O	 (NNP 2))))	244	245
1	10	was	be	VBD	cop	11	O	 (VP (VBD was)	246	249
1	11	116	116	CD	root	0	NUMBER	 (NP (NP (NP (NP (CD 116))	250	253
1	12	per	per	IN	case	17	O	 (PP (IN per)	254	257
1	13	100	100	CD	compound	14	NUMBER	 (NP (NP (QP (CD 100)	258	261
1	14	000	000	CD	nummod	17	NUMBER	 (CD 000))	262	265
1	15	person	person	NN	compound	17	O	 (NN person)	266	272
1	16	-	-	HYPH	punct	17	O	 (HYPH -)	272	273
1	17	days	day	NNS	nmod	11	O	 (NNS days))	273	277
1	18	prior	prior	RB	advmod	17	O	 (ADVP (RB prior)	278	283
1	19	to	to	IN	case	21	O	 (PP (IN to)	284	286
1	20	booster	booster	NN	compound	21	O	 (NP (NN booster)	287	294
1	21	vaccination	vaccination	NN	obl	18	O	 (NN vaccination)))))))	295	306
1	22	and	and	CC	cc	23	O	 (CC and)	307	310
1	23	12.8	12.8	CD	conj	11	NUMBER	 (NP (NP (CD 12.8))	311	315
1	24	per	per	IN	case	26	O	 (PP (IN per)	316	319
1	25	100	100	CD	compound	26	NUMBER	 (NP (NP (QP (CD 100)	320	323
1	26	000	000	CD	nmod	23	NUMBER	 (CD 000)))	324	327
1	27	after	after	IN	case	29	O	 (PP (IN after)	328	333
1	28	booster	booster	NN	compound	29	O	 (NP (NN booster)	334	341
1	29	vaccination	vaccination	NN	nmod	26	O	 (NN vaccination))))))	342	353
1	30	,	,	,	punct	11	O	 (, ,))	353	354
1	31	**	**	NFP	dep	11	O	 (X (NFP **)))	355	357
1	32	for	for	IN	case	36	O	 (PP (IN for)	357	360
1	33	an	a	DT	det	36	O	 (NP (NP (DT an)	361	363
1	34	estimated	estimate	VBN	amod	36	O	 (VBN estimated)	364	373
1	35	relative	relative	JJ	amod	36	O	 (JJ relative)	374	382
1	36	reduction	reduction	NN	obl	11	O	 (NN reduction))	383	392
1	37	of	of	IN	case	39	O	 (PP (IN of)	393	395
1	38	93	93	CD	nummod	39	PERCENT	 (NP (CD 93)	396	398
1	39	%	%	NN	nmod	36	PERCENT	 (NN %)))))	398	399
1	40	(	(	-LRB-	punct	42	O	 (PRN (-LRB- -LRB-) (NP (NP (NN hazard) (NN ratio)) (, ,) (NP (CD 0.07) (PRN (-LRB- [) (NP (NML (CD 95) (NN %)) (NN CI)) (, ,) (NP (CD 0.02) (HYPH -) (CD 0.2)) (-RRB- ])))) (-RRB- -RRB-))) (. .)))	400	401
1	41	hazard	hazard	NN	compound	42	O		401	407
1	42	ratio	ratio	NN	dep	11	O		408	413
1	43	,	,	,	punct	42	O		413	414
1	44	0.07	0.07	CD	appos	42	NUMBER		415	419
1	45	[	[	-LRB-	punct	48	O		420	421
1	46	95	95	CD	nummod	47	PERCENT		421	423
1	47	%	%	NN	compound	48	PERCENT		423	424
1	48	CI	ci	NN	appos	44	O		425	427
1	49	,	,	,	punct	48	O		427	428
1	50	0.02	0.02	CD	nummod	52	NUMBER		429	433
1	51	-	-	HYPH	punct	52	NUMBER		433	434
1	52	0.2	0.2	CD	dep	48	NUMBER		434	437
1	53	]	]	-RRB-	punct	48	O		437	438
1	54	)	)	-RRB-	punct	42	O		438	439
1	55	.	.	.	punct	11	O		439	440

2	1	The	the	DT	det	4	O	 (ROOT (S (NP (DT The)	441	444
2	2	booster	booster	NN	compound	3	O	 (NML (NN booster)	445	452
2	3	vaccine	vaccine	NN	compound	4	O	 (NN vaccine))	453	460
2	4	doses	dose	NNS	nsubj	5	O	 (NNS doses))	461	466
2	5	reduced	reduce	VBN	root	0	O	 (VP (VBN reduced)	467	474
2	6	equally	equally	RB	advmod	5	O	 (ADVP (RB equally)	475	482
2	7	the	the	DT	det	8	O	 (NP (NP (DT the)	483	486
2	8	risk	risk	NN	obl:npmod	6	O	 (NN risk))	487	491
2	9	of	of	IN	case	13	O	 (PP (IN of)	492	494
2	10	symptomatic	symptomatic	JJ	amod	13	O	 (NP (ADJP (JJ symptomatic)	495	506
2	11	and	and	CC	cc	12	O	 (CC and)	507	510
2	12	asymptomatic	asymptomatic	JJ	conj	10	O	 (JJ asymptomatic))	511	523
2	13	infection	infection	NN	nmod	8	CAUSE_OF_DEATH	 (NN infection))))))	524	533
2	14	.	.	.	punct	5	O	 (. .)))	533	534

3	1	"	"	``	punct	2	O	 (ROOT (FRAG (`` ")	534	535
3	2	**	**	NFP	root	0	O	 (NP (NFP **))	535	537
3	3	https://jamanetwork.com/journals/jama/fullarticle/2788105#:~:text=The%20incidence%20of%20SARS%2DCoV,of%20symptomatic%20and%20asymptomatic%20infection	https://jamanetwork.com/journals/jama/fullarticle/2788105#:~:text=the%20incidence%20of%20sars%2dcov,of%20symptomatic%20and%20asymptomatic%20infection	ADD	dep	2	O	 (NP (ADD https://jamanetwork.com/journals/jama/fullarticle/2788105#:~:text=The%20incidence%20of%20SARS%2DCoV,of%20symptomatic%20and%20asymptomatic%20infection))	538	687
3	4	.	.	.	punct	2	O	 (. .)))	687	688

4	1	That	that	DT	nsubj	3	O	 (ROOT (S (NP (DT That))	689	693
4	2	also	also	RB	advmod	3	O	 (ADVP (RB also))	694	698
4	3	prevent	prevent	VBP	root	0	O	 (VP (VBP prevent)	699	706
4	4	transmission	transmission	NN	obj	3	O	 (NP (NN transmission))	707	719
4	5	because	because	IN	mark	13	O	 (SBAR (IN because)	720	727
4	6	people	people	NNS	nsubj	13	O	 (S (NP (NP (NNS people))	728	734
4	7	who	who	WP	nsubj:pass	10	O	 (SBAR (WHNP (WP who))	735	738
4	8	are	be	VBP	aux:pass	10	O	 (S (VP (VBP are)	739	742
4	9	not	not	RB	advmod	10	O	 (RB not)	743	746
4	10	infected	infect	VBN	acl:relcl	6	O	 (VP (VBN infected))))))	747	755
4	11	can	can	MD	aux	13	O	 (VP (MD can)	756	759
4	12	not	not	RB	advmod	13	O	 (RB not)	759	762
4	13	transmit	transmit	VB	advcl	3	O	 (VP (VB transmit))))))	763	771
4	14	.	.	.	punct	3	O	 (. .)))	771	772

5	1	If	if	IN	mark	7	O	 (ROOT (S (SBAR (IN If)	774	776
5	2	by	by	IN	mark	4	O	 (S (PP (IN by)	777	779
5	3	"	"	``	punct	4	O	 (S (`` ")	780	781
5	4	prevent	prevent	VB	advcl	7	O	 (VP (VB prevent))	781	788
5	5	"	"	''	punct	4	O	 ('' ")))	788	789
5	6	you	you	PRP	nsubj	7	O	 (NP (PRP you))	790	793
5	7	mean	mean	VBP	advcl	16	O	 (VP (VBP mean)	794	798
5	8	prevent	prevent	VB	xcomp	7	O	 (VP (VB prevent)	799	806
5	9	100	100	CD	nummod	10	PERCENT	 (NP (NP (CD 100)	807	810
5	10	%	%	NN	obj	8	PERCENT	 (NN %))	810	811
5	11	of	of	IN	case	13	O	 (PP (IN of)	812	814
5	12	the	the	DT	det	13	O	 (NP (DT the)	815	818
5	13	infections	infection	NNS	nmod	10	CAUSE_OF_DEATH	 (NNS infections))))))))	819	829
5	14	,	,	,	punct	16	O	 (, ,)	829	830
5	15	there	there	EX	expl	16	O	 (NP (EX there))	831	836
5	16	is	be	VBZ	root	0	O	 (VP (VBZ is)	837	839
5	17	nothing	nothing	NN	nsubj	16	O	 (NP (NP (NN nothing))	840	847
5	18	that	that	WDT	nsubj	20	O	 (SBAR (WHNP (WDT that))	848	852
5	19	can	can	MD	aux	20	O	 (S (VP (MD can)	853	856
5	20	do	do	VB	acl:relcl	17	O	 (VP (VB do)	857	859
5	21	that	that	DT	obj	20	O	 (NP (NP (DT that))	860	864
5	22	,	,	,	punct	21	O	 (, ,)	864	865
5	23	no	no	DT	det	24	O	 (NP (DT no)	866	868
5	24	infection	infection	NN	conj	21	CAUSE_OF_DEATH	 (NN infection))	869	878
5	25	or	or	CC	cc	26	O	 (CC or)	879	881
5	26	vaccine	vaccine	NN	conj	21	O	 (NP (NN vaccine)))	882	889
5	27	in	in	IN	case	28	O	 (PP (IN in)	890	892
5	28	history	history	NN	obl	20	O	 (NP (NP (NN history))	893	900
5	29	of	of	IN	case	30	O	 (PP (IN of)	901	903
5	30	science	science	NN	nmod	28	O	 (NP (NN science)))))))))))	904	911
5	31	.	.	.	punct	16	O	 (. .)))	911	912

6	1	Contrary	contrary	JJ	advmod	10	O	 (ROOT (S (ADVP (JJ Contrary)	913	921
6	2	to	to	IN	case	4	O	 (PP (IN to)	922	924
6	3	popular	popular	JJ	amod	4	O	 (NP (JJ popular)	925	932
6	4	belief	belief	NN	obl	1	O	 (NN belief))))	933	939
6	5	,	,	,	punct	10	O	 (, ,)	939	940
6	6	even	even	RB	advmod	7	O	 (NP (RB even)	941	945
6	7	smallpox	smallpox	NN	nsubj	10	CAUSE_OF_DEATH	 (NP (NN smallpox))	946	954
6	8	and	and	CC	cc	9	O	 (CC and)	955	958
6	9	measles	measles	NNS	conj	7	CAUSE_OF_DEATH	 (NP (NNS measles)))	959	966
6	10	infected	infect	VBD	root	0	O	 (VP (VBD infected)	967	975
6	11	people	people	NNS	nsubj	13	O	 (PRN (S (NP (NNS people))	976	982
6	12	can	can	MD	aux	13	O	 (VP (MD can)	983	986
6	13	get	get	VB	parataxis	10	O	 (VP (VB get)	987	990
6	14	re-infections	re-infection	NNS	obj	13	O	 (NP (NNS re-infections))	991	1004
6	15	,	,	,	punct	13	O	 (, ,)	1004	1005
6	16	though	though	IN	mark	20	O	 (SBAR (IN though)	1006	1012
6	17	those	those	DT	nsubj	20	O	 (S (NP (DT those))	1013	1018
6	18	are	be	VBP	cop	20	O	 (VP (VBP are)	1019	1022
6	19	largely	largely	RB	advmod	20	O	 (ADJP (RB largely)	1023	1030
6	20	asymptomatic	asymptomatic	JJ	advcl	13	O	 (JJ asymptomatic)))))	1031	1043
6	21	(	(	-LRB-	punct	22	O	 (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009509#ppat.1009509.ref007)))) (-RRB- -RRB-)))))) (SBARQ (WHADVP (WRB Why)) (SQ (VBP do) (NP (PRP you)) (VP (VB try) (S (VP (TO to) (VP (VB disprove) (NP (DT the) (NNP CDC)) (PP (IN with) (NP (NN fringe) (NNS studies)))))))))) (. ?)))	1044	1045
6	22	see	see	VB	parataxis	13	O		1045	1048
6	23	https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009509#ppat.1009509.ref007	https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009509#ppat.1009509.ref007	NN	obj	22	O		1049	1148
6	24	)	)	-RRB-	punct	22	O		1148	1149
6	25	Why	why	WRB	advmod	28	O		1151	1154
6	26	do	do	VBP	aux	28	O		1155	1157
6	27	you	you	PRP	nsubj	28	O		1158	1161
6	28	try	try	VB	ccomp	10	O		1162	1165
6	29	to	to	TO	mark	30	O		1166	1168
6	30	disprove	disprove	VB	xcomp	28	O		1169	1177
6	31	the	the	DT	det	32	O		1178	1181
6	32	CDC	CDC	NNP	obj	30	ORGANIZATION		1182	1185
6	33	with	with	IN	case	35	O		1186	1190
6	34	fringe	fringe	NN	compound	35	O		1191	1197
6	35	studies	study	NNS	obl	30	O		1198	1205
6	36	?	?	.	punct	10	O		1205	1206

7	1	Like	like	IN	mark	3	O	 (ROOT (S (SBAR (IN Like)	1207	1211
7	2	I	I	PRP	nsubj	3	O	 (S (NP (PRP I))	1212	1213
7	3	said	say	VBD	advcl	5	O	 (VP (VBD said))))	1214	1218
7	4	,	,	,	punct	5	O	 (, ,)	1218	1219
7	5	stop	stop	VB	root	0	O	 (VP (VB stop)	1220	1224
7	6	spreading	spread	VBG	xcomp	5	O	 (S (VP (VBG spreading)	1225	1234
7	7	misinformation	misinformation	NN	obj	6	O	 (NP (NN misinformation)))))	1235	1249
7	8	.	.	.	punct	5	O	 (. .)))	1249	1250

